BE1002663A4 - Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1002663A4
BE1002663A4 BE8800732A BE8800732A BE1002663A4 BE 1002663 A4 BE1002663 A4 BE 1002663A4 BE 8800732 A BE8800732 A BE 8800732A BE 8800732 A BE8800732 A BE 8800732A BE 1002663 A4 BE1002663 A4 BE 1002663A4
Authority
BE
Belgium
Prior art keywords
medicaments
preparation
somatostatin derivatives
novel somatostatin
novel
Prior art date
Application number
BE8800732A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1002663A4 publication Critical patent/BE1002663A4/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE8800732A 1987-06-29 1988-06-27 Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments. BE1002663A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
BE1002663A4 true BE1002663A4 (fr) 1991-04-30

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800732A BE1002663A4 (fr) 1987-06-29 1988-06-27 Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments.

Country Status (15)

Country Link
JP (1) JPS6426599A (pl)
KR (1) KR890000520A (pl)
AU (1) AU1840988A (pl)
BE (1) BE1002663A4 (pl)
CH (1) CH679045A5 (pl)
DK (1) DK353788A (pl)
ES (1) ES2010283A6 (pl)
FR (1) FR2617171B1 (pl)
GB (1) GB2206352B (pl)
IL (1) IL86876A0 (pl)
IT (1) IT1221065B (pl)
LU (1) LU87262A1 (pl)
NL (1) NL8801640A (pl)
NZ (1) NZ225188A (pl)
SE (1) SE8802413L (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
CA2053250A1 (en) * 1989-04-26 1990-10-27 David H. Coy Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
EP1198478B1 (en) * 2000-07-31 2005-03-23 Dabur Research Foundation Somatostatin analogs and their use for the treatment of cancer
ES2306766T3 (es) 2001-03-08 2008-11-16 The Administrators Of The Tulane Educational Fund Antagonistas de somatostatina.
HUP0303727A2 (hu) * 2001-04-09 2004-03-01 The Administrators Of The Tulane Educational Fund Szomatosztatin agonisták és ezek alkalmazása
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0157753A1 (en) * 1984-03-26 1985-10-09 TECHLAND, Société Anonyme New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0157753A1 (en) * 1984-03-26 1985-10-09 TECHLAND, Société Anonyme New somatostatin compounds, process for their synthesis, preparation for veterinary use containing said compound and process for the treatment of animals
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives

Also Published As

Publication number Publication date
NZ225188A (en) 1991-04-26
GB8815257D0 (en) 1988-08-03
KR890000520A (ko) 1989-03-15
GB2206352A (en) 1989-01-05
CH679045A5 (pl) 1991-12-13
DK353788A (da) 1988-12-30
LU87262A1 (fr) 1989-03-08
AU1840988A (en) 1989-01-05
DK353788D0 (da) 1988-06-27
GB2206352B (en) 1990-10-31
IT1221065B (it) 1990-06-21
NL8801640A (nl) 1989-01-16
SE8802413D0 (sv) 1988-06-28
FR2617171B1 (fr) 1994-10-14
FR2617171A1 (fr) 1988-12-30
IT8848133A0 (it) 1988-06-28
ES2010283A6 (es) 1989-11-01
JPS6426599A (en) 1989-01-27
SE8802413L (sv) 1988-12-30
IL86876A0 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
BE1002663A4 (fr) Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments.
FR2430419A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
FR2444681A1 (fr) Nouvelles 1,4-dihydropyridines, leur preparation et leur application comme medicaments
NO871939D0 (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
NO168654C (no) Fremgangsmaate for polymerisering av 1,3-butadien.
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments
FR2378015A1 (fr) Nouveaux derives de la benzo(f)isoquinoleine, leur preparation et leur application comme medicaments
FR2403341A1 (fr) Nouvelles dibenzo(a,d)cyclooctene,5,12-(et 6,12)-imines, leur preparation et leur application comme medicament
FR2398736A1 (fr) Derives a-halogenomethyles d'aminoacides, leur procede de preparation et leur utilisation comme antiallergiques
FR2395995A1 (fr) Nouveaux derives d'a-vinylaminoacides, leur preparation et leur utilisation comme inhibiteurs de la decarboxylase des aminoacides aromatiques
FR2392011A1 (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
IT8722802A0 (it) Preparazione di trifluorometilbenzonitrile da trifluorometilbenzaldeide.
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs
FR2365557A1 (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments
FR2376155A1 (fr) Thiophosphorylguanidines anti-parasitaires et leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19960630